Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
NCT06195943 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2026-04-08
Summary
This study will be a pilot study to evaluate the feasibility, safety and acceptability of Exercise and Liver FITness (EL-FIT), a mHealth exercise training program previously validated in patients with cirrhosis in patients with nonalcoholic steatohepatitis.
Conditions
- NASH - Nonalcoholic Steatohepatitis
- NASH
- Exercise
- Liver
Interventions
- BEHAVIORAL
-
Exercise Intervention with use of El-Fit App
Along with wearing their Fitbit daily, subjects will be asked to use El-Fit app to participant in daily exercise as much or a little as they want over the course of the study.
Sponsors & Collaborators
-
Milton S. Hershey Medical Center
lead OTHER
Principal Investigators
-
Justin G Tondt, MD · Penn State Health
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-01
- Primary Completion
- 2026-03-01
- Completion
- 2026-03-01
Countries
- United States
Study Locations
More Related Trials
-
Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease
NCT04988204 ·Status: COMPLETED ·Phase: NA
-
Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis
NCT05357352 ·Status: COMPLETED
-
Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06994234 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
NCT01591200 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
NCT02927314 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate MET642 in Patients With NASH
NCT04773964 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH
NCT05357248 ·Status: COMPLETED ·Phase: NA
-
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT03248882 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
NCT02457286 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.
NCT03776175 ·Status: COMPLETED ·Phase: PHASE2
-
Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07199491 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH
NCT04006145 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)
NCT04929483 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
NCT01987310 ·Status: WITHDRAWN ·Phase: NA
-
6-week Safety and PD Study in Adults With NAFLD
NCT03256526 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease
NCT05768334 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease
NCT05364684 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT03812029 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Pain Management and Opioid Safety for Patients With Cirrhosis
NCT05128578 ·Status: COMPLETED ·Phase: NA
-
Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease
NCT05754385 ·Status: COMPLETED ·Phase: NA
-
Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
NCT03611101 ·Status: COMPLETED
-
NASH AMPK Exercise Dosing (AMPED) Trial
NCT04987879 ·Status: RECRUITING ·Phase: NA
-
The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
NCT04134091 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Experimental Medication BMS-986036 Given to Healthy Participants
NCT03445208 ·Status: COMPLETED ·Phase: PHASE1
-
PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis
NCT05022693 ·Status: COMPLETED ·Phase: PHASE1